Status:
COMPLETED
IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Breast Cancer
BRCA1 Mutation
Eligibility:
All Genders
18+ years
Brief Summary
Relationship between the presence of the BRCA mutation (BReast Cancer) and outcomes is unclear in high-risk early breast cancers (BC). This study is a multi-center retrospective cohort of patients tr...
Eligibility Criteria
Inclusion
- Patients older than 18 years old,
- Histologically confirmed invasive early breast cancer
- Neo-adjuvant and/or adjuvant chemotherapy with the first cure of chemotherapy received between January 1st, 2003 and December 31th, 2013
Exclusion
- Clinical, radiological or histological confirmed metastatic disease
- Non-invasive breast cancer,
- Patients who received incomplete treatment
- Patients who did not speak French
Key Trial Info
Start Date :
July 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 21 2018
Estimated Enrollment :
2295 Patients enrolled
Trial Details
Trial ID
NCT04012229
Start Date
July 28 2017
End Date
June 21 2018
Last Update
July 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Jean Minjoz
Besançon, Franche-Comté, France, 25030